A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Part of paid clinical trials in Duarte, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT07741968
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Breast Carcinoma
- Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma
- Endometrial Carcinoma
- Malignant Female Reproductive System Neoplasm
- Ovarian Carcinoma
- Ovarian Carcinosarcoma
- Stage III Cervical Cancer AJCC v8
- Stage III Vaginal Cancer AJCC v8
- Stage III Vulvar Cancer AJCC v8
- Stage IV Cervical Cancer AJCC v8
- Stage IV Vaginal Cancer AJCC v8
- Stage IV Vulvar Cancer AJCC v8
- Triple-Negative Breast Carcinoma
- Uterine Corpus Carcinosarcoma
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Best Practice — OTHERParticipate in Navigating Cancer Program
- Interview — OTHERAncillary studies
- Supportive Care — OTHERParticipate in Mindful Living Program
- Supportive Care — OTHERComplete skills practice
- Supportive Care — OTHERReceive access to videos and website
- Survey Administration — OTHERAncillary studies
- Telephone-Based Intervention — BEHAVIORALReceive check-in call
Study Details
This clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women with gynecologic or breast cancer. FOP is the fear patients experience from the possibility that their cancer could grow, spread, or get worse. Managing FOP is a leading unmet concern of cancer patients. High levels of FOP are associated with distress, depression, and increased health care costs, despite this, access to resources to address FOP remain limited. The blended e-health intervention in this trial offers remote group sessions along with online sessions to help patients access the information. Session content incorporates values-based goal setting and skills practices to manage unhelpful beliefs about worry and promote helpful coping behaviors. The sessions may help patients recognize unhelpful thoughts and behaviors which reinforce worry. A blended e-health intervention may be an effective way to improve FOP in women with gynecologic or breast cancer.
Key Dates
- First listed
- Aug 3, 2026
- Start date
- Feb 22, 2027
- Status verified
- Jul 2026
- Primary completion
- Jan 16, 2028
- Completion
- Jan 16, 2028
Study Design
- Enrollment
- 126 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm I (Mindful Living Program)Patients participate in the Mindful Living Program over 6 weeks consisting of group sessions over 60 minutes each during weeks 1, 3, and 6 and online sessions during weeks 2, 4, and 5. Patients also practice skills related to attention training, detached mindfulness, worry postponement, guided imagery, and other mindfulness practices 10-12 minutes daily for 6 days a week. Additionally, patients receive a check-in call over 15-20 minutes at week 3-4 and access to videos as well as a website containing a journal, community forum, and resource library on study.
- Active Comparator: Arm II (Navigating Cancer Program)Patients participate in the Navigating Cancer Program over 6 weeks consisting of group sessions over 60 minutes each during weeks 1, 3, and 6 and online sessions during weeks 2, 4, and 5. Patients also receive a check-in call over 15-20 minutes at week 3-4.
Primary Outcome Measure
Recruitment rate (Feasibility of enrollment) [ Time Frame: Up to 18 months ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | Anne Reb Anne Reb (PRINCIPAL_INVESTIGATOR) |
| City of Hope at Irvine Lennar | Irvine | California | 92618 | Anne Reb Anne Reb (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Duarte, CA
Related Studies
- Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial CancerPHASE3 · Recruiting · University of Utah · Maywood, Illinois
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerPHASE2 · Recruiting · National Cancer Institute (NCI) · Aurora, Colorado
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerRecruiting · SWOG Cancer Research Network · Anchorage, Alaska
- A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian CancerRecruiting · NRG Oncology · Birmingham, Alabama